FDA — authorised 22 June 1998
- Application: NDA020918
- Marketing authorisation holder: NOVO NORDISK
- Local brand name: GLUCAGEN
- Indication: POWDER — INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Status: approved
🇺🇸 Glucagon Hydrochloride Solution in United States
FDA authorised Glucagon Hydrochloride Solution on 22 June 1998
Marketing authorisation
Other Endocrinology approved in United States
Frequently asked questions
Is Glucagon Hydrochloride Solution approved in United States?
Yes. FDA authorised it on 22 June 1998.
Who is the marketing authorisation holder for Glucagon Hydrochloride Solution in United States?
NOVO NORDISK holds the US marketing authorisation.